ASX shares in the healthcare, consumer staples and information technology sectors were leading the ASX 200 before November. What happened?
The post Why healthcare, tech and consumer staples shares underperformed the ASX 200 in November appeared first on Motley Fool Australia. –
ASX healthcare, tech and consumer staples shares were market leading sectors at the height of COVID-19 and lockdown measures. Fast forward to reopening borders and vaccine hopes and these sectors underperformed the S&P/ASX 200 Index (ASX: XJO) in November. With the ASX 200 gaining nearly 10% in November, let’s take a closer look at those shares lagging behind.
ASX consumer staples shares losing steam
The S&P/ASX Consumer Staples Index was up 0.03% in November. Pantry stocking and higher in-home consumption pushed consumer staple heavyweights Woolworths Group Ltd (ASX: WOW) and Coles Group Ltd (ASX: COL) share prices higher throughout the year. But the supermarket giants remained largely flat in November with the Woolworths share price falling 4% and Coles share price down 1%.
Despite the weak performance, many brokers remain positive on the Woolworths share price, anticipating a strong Christmas trading period. Big brokers including Credit Suisse Group, Morgan Stanley and UBS Group (USA) retain price targets between $40.80 and $44.00 for Woolworths shares.
Mid-cap consumer staple shares also faced significant challenges in relation to rising tensions with China. These include recent tariffs on wine and the blocking of China’s Mengnui Dairy’s acquisition of Lion Dairy. This has seen the A2 Milk Company Ltd (ASX: A2M) share price unable to pick up steam and remain flat for the month. Meanwhile, the Treasury Wine Estates Ltd (ASX:TWE) share price was down 7% for November.
Healthcare and technology shares taking a breather
The S&P/ASX 200 Info Tech Index (ASX: XIJ) was up 4.70% in November which, whilst decent enough, underperformed the wider ASX 200 by nearly 5%. Many tech shares are taking a breather after spectacular runs to new highs throughout the year. These include the likes of Afterpay Ltd (ASX: APT) plateauing after hitting $100 in October and NextDC Ltd (ASX: NXT) falling 10% after more than doubling this year. Xero Limited (ASX: XRO), on the other hand, managed to hit an all-time record high of $135 in late November.
Similarly, the S&P/ASX Healthcare Index was up 2.72% in November. Healthcare heavyweight CSL Limited (ASX: CSL) closed 4% higher, but its shares are largely flat year to date.
Elsewhere, the Fisher & Paykel Healthcare Corp Ltd (ASX: FPH) share price was down 1.25% after its 60% share price run this year.
Sonic Healthcare Limited (ASX: SHL) was the worst performing large cap healthcare stock, down almost 6%. Its shares are relatively flat year to date following the adverse impacts of lockdown, coronavirus infection fears and cancellations of elective surgeries. The company’s core base laboratory business revenues are improving with most regions up on prior year levels. This includes negative but improving growth in the United States and United Kingdom. Sonic transitioned its business into providing significant support for COVID testing, especially in the US, Europe and Australia.
ASX tech and healthcare sectors still delivered positive returns in November. One could argue that their underperformance against the boarder ASX 200 in November was largely attributable to the surge in the share prices of the big four banks.
These Dividend Stocks Could Be Your Next Cash Kings (FREE REPORT)
Motley Fool Australia’s Dividend experts recently released a brand-new FREE report revealing 3 dividend stocks with JUICY franked dividends that could keep paying you meaty dividends for years to come.
Our team of investors think these 3 dividend stocks should be a ‘must consider’ for any savvy dividend investor. But more importantly, could potentially make Australian investors a heap of passive income.
Don’t miss out! Simply click the link below to grab your free copy and discover these 3 high conviction stocks now.
Returns As of 6th October 2020
- Why the Afterpay (ASX:APT) share price and these ASX stocks could get a boost next week
- Fund managers are snapping up these ASX stocks at a record pace
- 2 ASX 200 healthcare shares that outperformed in November
- These were the worst performing ASX 200 shares in November
- ASX 200 drops on Monday
Lina Lim has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. and Xero. The Motley Fool Australia owns shares of and has recommended A2 Milk and Treasury Wine Estates Limited. The Motley Fool Australia owns shares of AFTERPAY T FPO, and Woolworths Limited. The Motley Fool Australia has recommended Sonic Healthcare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.
The post Why healthcare, tech and consumer staples shares underperformed the ASX 200 in November appeared first on Motley Fool Australia.